Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytrol Actual Use Study
NCT04534491Phase 3Completed
- Sponsor
- Bayer
- Start
- May 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxybutynin in overactive bladder (OAB), sponsored by Bayer. Started May 2010; status: completed.
02
Drugs
oxybutynin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT04534491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04534491.